Publications by authors named "Susan D Demo"

Claim this Profile
A
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
Matt I Gross, Susan D Demo, Jennifer B Dennison, Lijing Chen, Tania Chernov-Rogan

Mol Cancer Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity.
Hao Li, Elizabeth L Ponder, Martijn Verdoes, Kristijana H Asbjornsdottir, Edgar Deu, Susan D Demo

Chem Biol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.
Tony Muchamuel, Michael Basler, Monette A Aujay, Erika Suzuki, Khalid W Kalim, Susan D Demo

Nat Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).
Han-Jie Zhou, Monette A Aujay, Mark K Bennett, Maya Dajee, Susan D Demo

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.
Deborah J Kuhn, Qing Chen, Peter M Voorhees, John S Strader, Kevin D Shenk, Susan D Demo

Blood· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.
Susan D Demo, Christopher J Kirk, Monette A Aujay, Tonia J Buchholz, Maya Dajee

Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
Todd R Pray, Francesco Parlati, Jianing Huang, Brian R Wong, Donald G Payan, Susan D Demo

Drug Resist Updat· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis